Molecular timeline of preclinical Alzheimer’s disease: why Autosomal Dominant Alzheimer’s Disease (ADAD) matters

José Miguel Laffita-Mesa

Open source

DOI
10.1136/jnnp-2026-339569
Published
2026-08-24
Container
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2026-339569,
  title = {Molecular timeline of preclinical Alzheimer’s disease: why Autosomal Dominant Alzheimer’s Disease (ADAD) matters},
  author = {José Miguel Laffita-Mesa},
  year = {2026},
  journal = {Journal of Neurology, Neurosurgery \& Psychiatry},
  doi = {10.1136/jnnp-2026-339569},
  url = {https://doi.org/10.1136/jnnp-2026-339569}
}

RIS

TY  - JOUR
TI  - Molecular timeline of preclinical Alzheimer’s disease: why Autosomal Dominant Alzheimer’s Disease (ADAD) matters
AU  - José Miguel Laffita-Mesa
PY  - 2026
JO  - Journal of Neurology, Neurosurgery & Psychiatry
DO  - 10.1136/jnnp-2026-339569
UR  - https://doi.org/10.1136/jnnp-2026-339569
ER  - 

APA

Laffita-Mesa, J. M. (2026). Molecular timeline of preclinical Alzheimer’s disease: why Autosomal Dominant Alzheimer’s Disease (ADAD) matters. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2026-339569

Source records